Stocks and InvestingStocks and Investing
Tue, January 25, 2022
Mon, January 24, 2022
Sun, January 23, 2022
Sat, January 22, 2022
Fri, January 21, 2022
Thu, January 20, 2022

Bradley Canino Maintained (ZNTL) at Strong Buy with Increased Target to $94 on, Jan 20th, 2022


Published on 2024-10-27 19:21:52 - WOPRAI, Bradley Canino
  Print publication without navigation


Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Increased Target from $88 to $94 on, Jan 20th, 2022.

Bradley has made no other calls on ZNTL in the last 4 months.



There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Bradley


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $97 on, Friday, December 17th, 2021
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $120 on, Thursday, November 11th, 2021
  • Robert Driscoll of "Wedbush" Maintained at Buy with Increased Target to $89 on, Wednesday, October 27th, 2021
  • Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $90 on, Wednesday, September 29th, 2021